Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir

Clinical Infectious Diseases

Volumn 33, Issue 12, 2001, Pages 2034-2039

  Sarisky, Robert T ^a   Cano, Rachel ^d   Nguyen, Tammy T ^a   Wittrock, Robert J ^a   Duffy, Karen E ^a   Clark, Phil ^a   Bartus, Joan O ^a   Bacon, Teresa H ^d   Caspers Velu, Laure ^d   Hodinka, Richard L ^e   Leary, Jeffry J ^a  

^a GLAXOSMITHKLINE   (France)

^b Childrens Hospital of Philadelphia and University of Pennsylvania School of Medicine   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

^d Hospital Saint Pierre ^*

^e Centre Hospitalier Universitaire St Pierre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DNA DIRECTED DNA POLYMERASE ALPHA; PENCICLOVIR; THYMIDINE KINASE;

ARTICLE; DRUG SENSITIVITY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TREATMENT OUTCOME; VIRUS ISOLATION; VIRUS RECOMBINANT;

ACYCLOVIR; AGED; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 0035893162     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338046     Document Type: Article

References (23)

1. Herpes simplex virus resistant to acyclovir: A study in a tertiary care center
2. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir
3. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir
4. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome
5. Progressive esophagitis from acyclovir-resistant herpes simplex: Clinical roles for DNA polymerase mutants and viral heterogeneity?
6. Chronic herpetic infection in an immunocompromised patient: Report of a case
7. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: Preliminary data
8. A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates
9. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients
10. Sensitivity of herpes virus isolates from acyclovir clinical tirals
11. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo
12. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents
13. Difference in incidence of spontaneous mutations distinct between herpes simplex virus types 1 and 2
14. Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility
15. Problems associated with the use of (E)-5-(2-bromovinyl)-2′-deoxyuridine for typing herpes simplex virus
16. Isolation and characterization of herpes simplex virus mutants containing engineered mutations at the DNA polymerase locus
17. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate
18. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir
19. Antiherpesvirus activity of 9-(4-hydroxy-3hydroxymethylbut-1-yl)guanine (BRL 39123) in cell culture
20. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis
21. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition
22. The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue
23. Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase